TerrAscend Corp. (TRSSF) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
TerrAscend Corp. (TRSSF) opera en el sector Healthcare, cotizado por última vez a $ con una capitalización de mercado de 0. Calificado con 43/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.
Ultimo analisis: 16 mar 2026TerrAscend Corp. (TRSSF) Resumen de Asistencia Médica y Tuberías
TerrAscend Corp. is a North American cannabis company focused on cultivation, processing, and retail sales of medical and adult-use cannabis. With a portfolio of recognized brands and a growing dispensary network, TerrAscend aims to establish a strong presence in key cannabis markets across the United States and Canada.
Tesis de Inversión
TerrAscend Corp. presents a notable research candidate within the expanding North American cannabis market. The company's vertically integrated business model, encompassing cultivation, processing, and retail, allows for greater control over the supply chain and enhanced profitability. With a gross margin of 51.3%, TerrAscend demonstrates strong operational efficiency. Growth will be driven by expansion of its dispensary network and increasing brand recognition. However, the company's negative profit margin of -32.1% and a high beta of 2.00 indicate significant risk and volatility. Investors should monitor progress toward profitability and navigate the evolving regulatory landscape.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Market capitalization of $0.60 billion reflects TerrAscend's current valuation in the cannabis market.
- Gross margin of 51.3% indicates strong operational efficiency in cannabis production and sales.
- Operates 27 dispensaries as of July 2022, providing a significant retail footprint across key markets.
- Negative P/E ratio of -2.43 suggests the company is currently unprofitable.
- Beta of 2.00 indicates high volatility compared to the broader market.
Competidores y Pares
Fortalezas
- Vertically integrated operations.
- Established brands (Apothecarium, Cookies, Kind Tree).
- Strategic dispensary locations.
- Strong gross margin (51.3%).
Debilidades
- Negative profit margin (-32.1%).
- High beta (2.00) indicating high volatility.
- Reliance on regulatory approvals.
- Limited geographic diversification.
Catalizadores
- Upcoming: Expansion of dispensary network into new states and provinces.
- Ongoing: Increasing brand awareness and customer loyalty through marketing initiatives.
- Ongoing: Product innovation and development to meet evolving consumer preferences.
- Upcoming: Potential acquisitions of complementary businesses to expand capabilities.
- Ongoing: Regulatory changes and legalization efforts in new jurisdictions.
Riesgos
- Ongoing: Intense competition from other cannabis companies.
- Ongoing: Evolving regulatory landscape and potential changes in cannabis laws.
- Potential: Fluctuations in cannabis prices affecting profitability.
- Potential: Economic downturn impacting consumer spending on cannabis products.
- Potential: Difficulty in obtaining financing due to the stigma surrounding the cannabis industry.
Oportunidades de crecimiento
- Expansion of Dispensary Network: TerrAscend has the opportunity to expand its retail footprint by opening new dispensaries in strategic locations. The company can leverage its existing brands, such as Apothecarium and Cookies, to attract customers and establish a strong presence in new markets. This expansion can drive revenue growth and increase market share. The timeline for this growth opportunity is ongoing, with potential for significant expansion over the next 3-5 years.
- Increased Brand Recognition and Loyalty: TerrAscend can invest in marketing and branding initiatives to increase brand recognition and loyalty among consumers. By building strong brand equity, the company can differentiate itself from competitors and attract a larger customer base. This growth opportunity is ongoing, with continuous efforts to enhance brand awareness and customer engagement.
- Product Innovation and Development: TerrAscend can focus on developing new and innovative cannabis products to meet evolving consumer preferences. This includes exploring new form factors, formulations, and consumption methods. By staying ahead of the curve in product innovation, the company can attract new customers and maintain its competitive edge. The timeline for new product development is typically 12-18 months.
- Strategic Acquisitions and Partnerships: TerrAscend can pursue strategic acquisitions and partnerships to expand its capabilities and market reach. This includes acquiring complementary businesses, such as cultivation facilities or processing facilities, or partnering with other cannabis companies to access new markets or technologies. The timeline for acquisitions and partnerships is variable, depending on the specific opportunities that arise.
- Expansion into New Geographies: TerrAscend can explore opportunities to expand its operations into new geographies, both within North America and internationally. This includes entering new states or provinces that have legalized cannabis, as well as exploring opportunities in emerging international markets. The timeline for geographic expansion is dependent on regulatory changes and market conditions.
Oportunidades
- Expansion of dispensary network.
- Increased brand recognition and loyalty.
- Product innovation and development.
- Strategic acquisitions and partnerships.
Amenazas
- Intense competition.
- Evolving regulatory landscape.
- Fluctuations in cannabis prices.
- Economic downturn affecting consumer spending.
Ventajas competitivas
- Vertically integrated operations provide control over the supply chain.
- Established brands like Apothecarium and Cookies create customer loyalty.
- Strategic dispensary locations provide access to key markets.
- Proprietary cultivation and processing techniques ensure product quality.
Acerca de TRSSF
TerrAscend Corp., incorporated in 2017 and headquartered in Mississauga, Canada, operates as a vertically integrated cannabis company, cultivating, processing, and selling medical and adult-use cannabis in both Canada and the United States. The company's operations span the entire cannabis value chain, from cultivation and processing to retail distribution. TerrAscend produces and distributes hemp-derived wellness products to retail locations and manufactures cannabis-infused artisan edibles. The company's retail footprint includes dispensaries operating under the Apothecarium brand in California and Pennsylvania, as well as Cookies dispensaries in Michigan and Toronto. TerrAscend owns various synergistic brands, including Gage Cannabis, Ilera Healthcare, Kind Tree, Prism, State Flower, Valhalla Confections, and Arise Bioscience Inc., allowing it to cater to a diverse range of consumer preferences and market segments. As of July 26, 2022, TerrAscend operated 27 dispensaries, solidifying its presence in key cannabis markets.
Qué hacen
- Cultivates medical and adult-use cannabis.
- Processes cannabis into various products.
- Sells cannabis through its own retail dispensaries.
- Distributes hemp-derived wellness products.
- Manufactures cannabis-infused artisan edibles.
- Operates dispensaries under the Apothecarium and Cookies brands.
- Owns various synergistic brands like Gage Cannabis and Kind Tree.
Modelo de Negocio
- Vertically integrated model encompassing cultivation, processing, and retail.
- Generates revenue through the sale of cannabis products at its dispensaries.
- Distributes hemp-derived wellness products to retail locations.
- Licenses brands and intellectual property.
Contexto de la Industria
TerrAscend operates in the rapidly evolving cannabis industry, characterized by increasing legalization and growing consumer acceptance. The North American cannabis market is experiencing substantial growth, driven by both medical and recreational use. Competition is intense, with numerous players vying for market share, including established cannabis companies and new entrants. TerrAscend's vertically integrated model and established brand portfolio position it to capitalize on this growth, but it must navigate regulatory complexities and compete effectively to maintain its market position.
Clientes Clave
- Medical cannabis patients seeking therapeutic relief.
- Adult-use cannabis consumers seeking recreational experiences.
- Retail partners who sell TerrAscend's hemp-derived wellness products.
Finanzas
Gráfico e información
Precio de la acción de TerrAscend Corp. (TRSSF): Price data unavailable
Últimas noticias
-
Washington Post Reported President Trump Expected To Announce A Medicare Pilot Program To Reimburse Patients' CBD Treatments
benzinga · 18 dic 2025
-
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
benzinga · 17 dic 2025
-
Hess Midstream Signs $100M Repurchase That Includes Class B Units Of Hess Midstream Operations From chevron Affiliate And Hess Midstream's Class A Shares From Public
benzinga · 5 ago 2025
-
'GOP-Led Congressional Panel Demands Investigation On Biden's Marijuana Rescheduling Process, Citing 'Deviations' And 'Mental Health Hazards'' -Marijuana Moment Report
benzinga · 10 jun 2025
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para TRSSF.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para TRSSF.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de TRSSF en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Últimas Noticias
Washington Post Reported President Trump Expected To Announce A Medicare Pilot Program To Reimburse Patients' CBD Treatments
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report
Hess Midstream Signs $100M Repurchase That Includes Class B Units Of Hess Midstream Operations From chevron Affiliate And Hess Midstream's Class A Shares From Public
'GOP-Led Congressional Panel Demands Investigation On Biden's Marijuana Rescheduling Process, Citing 'Deviations' And 'Mental Health Hazards'' -Marijuana Moment Report
Liderazgo: Ziad Ghanem
CEO
Ziad Ghanem is the CEO of TerrAscend Corp. His background includes extensive experience in the cannabis industry, with a focus on operational excellence and strategic growth. He has a proven track record of building and scaling cannabis businesses, driving revenue growth, and improving profitability. Prior to joining TerrAscend, Ziad held leadership positions at other cannabis companies, where he oversaw cultivation, processing, and retail operations. His expertise in the cannabis industry makes him well-suited to lead TerrAscend through its next phase of growth.
Historial: Under Ziad Ghanem's leadership, TerrAscend has focused on expanding its retail footprint, strengthening its brand portfolio, and improving its operational efficiency. He has overseen the acquisition and integration of several key assets, including Gage Cannabis, which has significantly expanded TerrAscend's presence in the Michigan market. He has also focused on driving revenue growth and improving profitability through strategic initiatives and cost management.
Información del mercado OTC de TRSSF
The OTC Other tier represents the lowest tier of the OTC market, indicating that TerrAscend Corp. may not meet the minimum financial or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies on the OTC Other tier often have limited information available to investors, and may be subject to less regulatory oversight compared to companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the potential for limited liquidity, lack of transparency, and higher likelihood of fraud or manipulation. Investors should exercise extreme caution and conduct thorough due diligence before investing in OTC Other stocks.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited liquidity due to lower trading volumes on the OTC market.
- Lack of transparency due to potentially limited financial disclosures.
- Higher potential for fraud or manipulation compared to listed exchanges.
- Increased volatility due to limited investor participation.
- Regulatory risks associated with the cannabis industry and OTC markets.
- Verify the company's financial statements and audit reports.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance and risk management practices.
- Monitor trading volume and bid-ask spreads to assess liquidity.
- Consult with a qualified financial advisor before investing.
- Understand the risks associated with investing in OTC stocks.
- Established operations in multiple states and Canada.
- Presence of well-known brands like Apothecarium and Cookies.
- Vertical integration across the cannabis value chain.
- Experienced management team with industry expertise.
TRSSF Preguntas Frecuentes sobre Acciones de Healthcare
¿Cuáles son los factores clave para evaluar TRSSF?
TerrAscend Corp. (TRSSF) actualmente tiene una puntuación IA de 43/100, indicando puntuación baja. Fortaleza clave: Vertically integrated operations.. Riesgo principal a monitorear: Ongoing: Intense competition from other cannabis companies.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de TRSSF?
TRSSF actualmente puntúa 43/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de TRSSF?
Los precios de TRSSF se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre TRSSF?
La cobertura de analistas para TRSSF incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en TRSSF?
Las categorías de riesgo para TRSSF incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Ongoing: Intense competition from other cannabis companies.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de TRSSF?
La relación P/E para TRSSF compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está TRSSF sobrevalorada o infravalorada?
Determinar si TerrAscend Corp. (TRSSF) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de TRSSF?
TerrAscend Corp. (TRSSF) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Information is based on available data as of 2026-03-16.
- OTC market data may be less reliable than data from major exchanges.
- AI analysis is pending and may provide further insights.